Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



Managed Access Program (MAP) to provide alpelisib (BYL719) for patients with PIK3CA-Related Overgrowth Spectrum (PROS)

Pediatrics

Pediatrics
N/A
Borst, Alexandra
NCT04085653
VICCPED1985

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: